WallStSmart

Churchill Capital Corp XI (CCXI)vs1RT Acquisition Corp. (ONCH)

VS

Smart Verdict

WallStSmart Research — data-driven comparison

ONCH leads profitability with a 0.0% profit margin vs 0.0%. ONCH earns a higher WallStSmart Score of 30/100 (F).

CCXI

Avoid

24

out of 100

Grade: F

Growth: 4.3Profit: 4.0Value: 5.0Quality: 6.0
Piotroski: 2/9

ONCH

Avoid

30

out of 100

Grade: F

Growth: 4.3Profit: 3.5Value: 4.7Quality: 5.5
Piotroski: 3/9

Key Strengths & Concerns

Side-by-side fundamental analysis

Key Strengths

CCXI0 strengths · Avg: 0/10

No standout strengths identified

ONCH0 strengths · Avg: 0/10

No standout strengths identified

Areas to Watch

CCXI4 concerns · Avg: 3.5/10
Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$779.80M3/10

Smaller company, higher risk/reward

Return on EquityProfitability
4.7%3/10

ROE of 4.7% — below average capital efficiency

ONCH4 concerns · Avg: 3.8/10
P/E RatioValuation
35.6x4/10

Premium valuation, high expectations priced in

Revenue GrowthGrowth
0.0%4/10

0.0% revenue growth

EPS GrowthGrowth
0.0%4/10

0.0% earnings growth

Market CapQuality
$222.53M3/10

Smaller company, higher risk/reward

Comparative Analysis Report

WallStSmart Research

Bull Case : CCXI

CCXI has a balanced fundamental profile.

Bull Case : ONCH

ONCH has a balanced fundamental profile.

Bear Case : CCXI

The primary concerns for CCXI are Revenue Growth, EPS Growth, Market Cap.

Bear Case : ONCH

The primary concerns for ONCH are P/E Ratio, Revenue Growth, EPS Growth.

Key Dynamics to Monitor

ONCH is growing revenue faster at 0.0% — sustainability is the question.

ONCH generates stronger free cash flow (-187,758), providing more financial flexibility.

Monitor SHELL COMPANIES industry trends, competitive dynamics, and regulatory changes.

Bottom Line

ONCH scores higher overall (30/100 vs 24/100). Both earn "Avoid" and "Avoid" ratings respectively — the choice depends on your investment horizon and risk tolerance.

This analysis is generated from publicly available financial data. Not financial advice.

Churchill Capital Corp XI

FINANCIAL SERVICES · SHELL COMPANIES · USA

ChemoCentryx, Inc., a clinical-stage biopharmaceutical company, focuses on the development and commercialization of new drugs for inflammatory disorders, autoimmune diseases, and cancer in the United States. The company is headquartered in Mountain View, California.

1RT Acquisition Corp.

FINANCIAL SERVICES · SHELL COMPANIES · USA

1RT Acquisition Corp. The company is headquartered in New York, New York.

Want to dig deeper into these stocks?